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Massive reduction of urea transporters in remnant kidney and large amounts of urea in a small volume of fluid and thus
brain of uremic rats. to conserve water efficiently. Moreover, urea is known to
Background. The facilitated urea transporters (UT), UT-A1, contribute to the urine concentrating mechanism [1–3].UT-A2, and UT-B1, are involved in intrarenal recycling of
In chronic renal failure (CRF), the concentrating abilityurea, an essential feature of the urinary concentrating mecha-
of the kidney declines. In addition, when the glomerularnism, which is impaired in chronic renal failure (CRF). In this
study, the expression of these UTs was examined in experimen- filtration rate decreases, the excretion of urea matches
tally induced CRF. the production only at the expense of a marked elevation
Methods. The abundance of mRNA was measured by North- in plasma urea concentration.ern analysis and that of corresponding proteins by Western
The concentration of urea in urine is achieved throughblotting in rats one and five weeks after 5/6 nephrectomy (Nx).
a vasopressin-dependent complex process, which enablesResults. At five weeks, urine output was enhanced threefold
with a concomitant decrease in urine osmolality. The marked urea to reach and maintain a high concentration in the
rise in plasma urea concentration and fall in urinary urea con- interstitium of the renal medulla, traversed by the termi-
centration resulted in a 30-fold decrease in the urine/plasma
nal collecting ducts. This process involves selective and(U/P) urea concentration ratio, while the U/P osmoles ratio
localized high permeability to urea in several specializedfell only fourfold. A dramatic decrease in mRNA abundance
for the three UTs was observed, bringing their level at five segments of the nephron [2, 3].
weeks to 1/10th or less of control values. Immunoblotting showed Several urea transporters (UTs) have now been cloned,
complete disappearance of the 97 and 117 kD bands of UT-A1, and their expression in kidney and other organs has been
and considerable reduction of UT-A2 and UT-B1 in the renal
studied in great detail [reviewed in 4–7]. They are allmedulla. Similar, but less intense, changes were observed at
facilitated transporters, enabling a 10 to 1000 times fasterone-week post-Nx. In addition to the kidney, UT-B1 is also
normally expressed in brain and testis. In the brain, its mRNA equilibration of urea across cell membranes than passive
expression remained normal one-week post-Nx, but decreased diffusion. Two subfamilies encoded by two different genes
to about 30% of normal at five-weeks post-Nx, whereas no and exhibiting 60% homology have been described: UT-Achange was seen in testis.
and UT-B [4]. UT-A1, expressed exclusively in the terminalConclusions. (1) The decline in urinary concentrating ability
inner medullary collecting duct (IMCD), is the vasopres-seen in CRF is largely due to a major reduction of UTs involved
in the process of urea concentration in the urine, while factors sin-dependent UT that enables the delivery of concen-
enabling the concentration of other solutes are less intensely trated urea in the inner medullary interstitium. UT-A2,
affected. (2) The marked reduction of brain UT expression in a transcriptional isoform of the same gene, expressedCRF may be responsible for brain edema of dialysis disequilib-
in thin descending limbs of Henle’s loops, and UT-B1,rium syndrome observed in some patients after fast dialysis.
expressed in the endothelium of descending vasa recta,
enable urea, at risk of escaping the kidney via the as-The largest fraction of nitrogenous wastes is excreted
cending vasa recta, to be reintroduced by countercurrentby the kidney in the form of urea. The high solubility of
exchange in descending tubular and vascular structuresthis molecule enables the mammalian kidney to excrete
of the medulla and thus to be returned to the inner
medulla [5]. The UT-A family also includes the recently
Key words: urinary concentrating activity, excretion, renal failure, dial-
cloned UT-A3 and UT-A4, two isoforms expressed inysis disequilibrium syndrome, testis, chronic renal failure, edema and
fast dialysis. the rat renal medulla. However, their exact localization
has not yet been studied [8].Received for publication December 4, 1999
Whereas UTs of the UT-A family are mostly restrictedand in revised form February 22, 2000
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abundance in the astrocyte network of the brain [9] and homogenized in appropriate medium for Northern or
Western blotting (discussed in the next section). Urinein Sertoli cells of testes [10]. The significance of facili-
tated urea transport in these two organs is not yet known. and plasma osmolality was determined by the freezing
point method (Roebling osmometer, Berlin, Germany),To our knowledge, the possible changes occurring in
the expression of UTs during CRF have not yet been and urea concentration was measured with a commercial
kit (Urea-Kit; BioMe´rieux, Marcy-l’Etoile, France).investigated. The focus of the present study was thus to
quantitate the expression of mRNA for these three UTs
Northern blot analysisand their corresponding proteins in rats with experimen-
tally induced renal failure. This was done by Northern and Total RNA from renal medulla, brain, and testis was
extracted after homogenization in RNANOW reagent (Bio-Western blot analyses in renal medulla, brain, and testis
of different groups of rats one and five weeks after 5/6 gentex, Seabrook, TX, USA). Revelation of mRNA for
both UT-A1 and UT-A2 was performed using the samerenal ablation. Water and urea handling were studied in
the same rats. This study reveals a dramatic decline in the cDNA probe (a rat clone of 771 bp) [11]. UT-B1 mRNA
was revealed by a rat 384 bp cDNA probe [11]. The probeexpression of all three UTs in renal medulla along with
a major selective fall of urea concentration capacity. UT-B1 for glyceraldehyde-3-phosphate dehydrogenase (G3PDH),
used as a reference, was bought from Clontech (Palo Alto,is also markedly diminished in brain but not in testis.
CA, USA). These cDNAs were radiolabeled by random
priming as previously described [12]. Northern analysis
METHODS
of 15 mg of total RNA from each sample was carried
Animals and induction of renal insufficiency out as previously described [12]. The abundance of UTs
was measured by densitometry and was expressed rela-Male Sprague-Dawley rats (Iffa Credo, L’arbresle,
France) weighing about 220 g were subjected to 5/6 renal tive to that of G3PDH in the same samples.
ablation (Nx) in a two-stage procedure. In the first stage,
Antibodiesunder pentobarbital anesthesia (Sanofi, LiBourne, France),
the right kidney was decapsulated to preserve the adre- The anti–UT-A antibody used in this study is a com-
mercially available affinity-purified polyclonal antibodynal gland, and its two poles (two thirds of kidney mass)
were excised. Bleeding was minimized by application raised in rabbit against the 19-amino acid C-terminal
peptide sequence common to UT-A1 and UT-A2 (anti-of collagen powder (Pangen, Fournier, France) on cut
surfaces and by finger pressure. In the second stage, rUT2 antibody; Alpha Diagnostic International, San An-
tonio, TX, USA).one week later, the left kidney was decapsulated and
removed. Control rats underwent laparotomy and kid- The anti–UT-B antibody was a rabbit polyclonal se-
rum prepared by Neosystem (Strasbourg, France). It wasney decapsulation, but both kidneys were left intact. Rats
were then housed individually in normal cages, had free raised against a 20 amino acid peptide (MEDIPTMVKV
DRGESQILST) located in the N-terminal sequence ofaccess to tap water, and received 20 g/day (that is, slightly
less than their spontaneous intake) of a standard rat rat UT-B [10, 13]. Its specificity was checked by immuno-
blotting of proteins extracted from rUT-B cRNA-injecteddiet containing 25% protein (M25; Extralabo, Provins,
France). In a first experiment, mRNA expression of UTs Xenopus oocytes, from rat renal medulla, brain, and testis.
Individual oocytes were injected with either 10 ngwas studied in two series of rats one week (early renal
failure, 5 Nx and 5 control rats) and five weeks after Nx cRNA under 50 nL or with 50 nL water. They were incu-
bated for 72 hours at 188C before harvesting proteins by(established CRF, 6 Nx and 5 control rats). In a second
experiment, the protein expression was examined in hypotonic lysis at 48C in sodium phosphate buffer 7.5
mmol/L (pH 7.4) supplemented with ethylenediamine-three rats with established CRF and in three control rats.
tetraacetic acid (EDTA) 1 mmol/L, pepstatin 1 mg/mL,
Blood and urine analysis leupeptin 1 mg/mL, and phenylmethylsulfonyl fluoride
(PMSF) 20 mg/mL. The lysate was centrifuged at 16,000 3 gFive days before the end of the in vivo study, rats
were placed individually in metabolic cages. During the for 30 minutes at 48C, and the pellet was washed. Immu-
noblotting was performed as described in the Westernlast two days, 24-hour urine was collected and analyzed.
After completion of the last urine collection, a blood blot analysis section.
Indirect immunofluorescence was performed to iden-sample was drawn from the jugular vein under pentobarbi-
tal anesthesia for measurement of hematocrit and plasma tify the renal structures that recognized the UT-B antise-
rum. The preimmune serum and antiserum were checkedconcentration of osmoles and urea. Kidneys, brain, and
one testis were removed. Kidneys were weighed and at 1:50, 1:100, and 1:200 dilutions. Cryostat sections (5 mm)
of a Sprague-Dawley rat kidney, fixed with 4% paraform-sliced. The regions of the medulla known to express UTs
(comprising the inner stripe of outer medulla and the aldehyde, were blocked in phosphate-buffered saline
(PBS; 10 mmol/L sodium and 2 mmol/L potassium phos-inner medulla) were dissected from the slices and pooled/
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phate buffer, pH 7.4, containing 3 mmol/L KCl and 137 which reached a relative weight equal to that of one
kidney of control rats. Urine output was enhanced three-mmol/L NaCl; Sigma, St. Louis, MO, USA) containing
1% bovine serum albumin for 15 minutes. They were fold with a concomitant decrease in urine osmolality.
Plasma concentration of urea increased about fourfoldincubated with the UT-B antiserum for 90 minutes at
room temperature. After three PBS washings, they were and sevenfold at one and five weeks post-Nx, whereas
urinary urea concentration fell to 20% of values seen inincubated with FITC-conjugated goat anti-rabbit IgG
(Jackson ImmunoResearch, West Grove, PA, USA) for control rats. As a result, the relative concentration of
urea in urine with respect to plasma (U/P urea) fell45 minutes at room temperature followed by three PBS
washings. Sections were counterstained with Evans blue dramatically from about 200 to less than 10 after five
weeks of CRF (Table 1). This dramatic fall was muchand mounted in N-propyl gallate antiquenching medium
(100 mmol/L Tris-base, pH 8.0, 50% glycerol, 2% larger than the simultaneous fall in U/P osmole ratio
(from 6.5 to 1.6), suggesting that the concentration ofN-propyl-gallate) before an examination with an Olym-
pus VANOX-T fluorescence microscope. urea in urine might be impaired by a selective defect
concerning urea more than other urinary solutes.
Western blot analysis
UT-B antibody characterizationKidneys were obtained from three rats with established
CRF and three control rats. The medullary tissue was Figure 1A shows that in rUT-B cRNA-injected oo-
cytes, the anti-rUT-B antiserum, but not the preimmuneminced finely and thoroughly homogenized in ice-cold
isolation solution (250 mmol/L sucrose, 10 mmol/L tri- serum, was able to recognize a protein band of 43 kD.
In H2O-injected oocytes, neither the antiserum nor pre-ethanolamine, pH 7.6, 1 mg/mL leupeptin, and 100 mg/mL
PMSF). Protein concentration was assayed with a BCA immune serum revealed any band. Figure 1B shows the
labeling of a 55 kD band in the inner stripe of outerprotein assay reagent kit (Pierce, Rockford, IL, USA).
Total protein concentration was adjusted to 3 mg/mL medulla and in the inner medulla of a normal rat kidney.
An additional faint 60 kD band was visible in upperwith isolation solution. Fifteen microgram proteins from
crude homogenates were size separated on 10% poly- inner medulla. Even after doubling the amount of protein
loaded (30 instead of 15 mg), the brain did not express aacrylamide minigels. The proteins were then transferred
electrophoretically to polyvinylidine fluoride (PVDF) positive signal. Bands of very weak intensity were visible
in the testis. These bands are in the same size range asmembrane (Polyscreen; NEN, Tokyo, Japan). Blots were
blocked with 5% nonfat dry milk in PBS containing 0.3% those reported in rat kidney by Timmer et al using a
UT-B antibody directed against a 19-amino acids peptideTween 20 for one hour and then incubated for one and a
half hours with specific antibody. After washing, the blots of the C-terminal sequence of human UT-B (abstract;
J Am Soc Nephrol 9:26A,1998).were incubated with a secondary antibody conjugated with
horseradish peroxidase for one hour. All incubations and In cross sections through the inner stripe of the outer
medulla, immunofluorescence using the UT-B antise-washing steps were carried out at room temperature. Anti-
body binding was revealed using an enhanced chemilumi- rum, but not the preimmune serum, revealed a strong
labeling of thin structures located in the central area ofnescence system (Western blot chemiluminescence reagent
plus; NEN). Equal loading and transfer of proteins were vascular bundles (Fig. 2A). These bundles are known to
comprise a few relatively narrow descending arterial vasachecked by visual inspection after staining blots with
Coomassie blue at the end of the procedure. Brain and recta and a greater number of wider ascending venous
vasa recta. The pattern of labeling observed in the sec-testis were not studied because no (or only too faint) bands
were detectable by the UT-B antiserum in these organs tions strongly suggests that only the arterial descending
vasa recta were recognized by the antibody, in agreement(discussed in the Results section) and because they do
not express transporters of the UT-A family [11, 14]. with the previously described location of UT-B [15]. No
labeling was observed in thin descending limbs of short-
Statistics looped nephrons, which are known to lie at the periphery
of the vascular bundles in the rat [16, 17]. In the deepData were expressed as means 6 SEM. Differences
were analyzed by Student’s t-test. They were considered inner stripe (an oblique section in Fig. 2B), the antibody
bound to a few vasa recta in the vascular bundles. Insignificant for P , 0.05.
addition, it revealed small round figures between the
tubules, which are most likely red blood cells trapped in
RESULTS
capillaries (Fig. 2B).
Renal function Taken together, these results indicate that the antise-
rum recognizes specifically the renal and red cell UT-BPhysiological data are shown in Table 1. A 5/6 renal
ablation resulted in a marked increase in plasma creati- transporter. The fact that it did not reveal any band in
the brain and only faint bands in the testis (in which thenine and a significant hypertrophy of the remnant kidney,
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Table 1. Body and kidney weight, and urine and blood parameters
Early renal failure one week Chronic renal failure five weeks
Control 5/6 Nx Control 5/6 Nx
N 5 5 5 6
Body weight g 27563 22564c 35462 305615a
Total kidney weight mg/100g body weight d 796626 34066c 668619 376620c
Plasma creatinine lmol/L 5263 145612c 5762 295640c
Urine flow rate ml/day 14.962.4c 48.163.8c 13.461.8 51.164.7c
UOsm mOsm/kg H2O 18656235 521643c 20986200 544646c
POsm mOsm/kg H2O 31564 331643a 32164 34062b
UOsm/POsm 5.960.7 1.660.1c 6.560.6 1.660.1c
Osmole excretion mOsm/day 25.660.5 24.560.6 26.961.6 26.961.6
Uurea mmol/L 10626140 202632c 12206173 261629c
Purea mmol/L 4.760.3 19.361.2c 6.460.4 44.665.5c
Uurea /Purea 234639 1162c 196635 761c
Urea excretion mmol/day 14.660.6 9.561.1a 15.261.0 12.760.4a
Values are means 6 SEM.
Abbreviations are: POsm and UOsm, plasma and urine osmolality; Purea and Uurea, plasma and urine urea concentration, respectively.
aP , 0.05, bP , 0.01, cP , 0.001 by Student’s t-test versus respective controls
d Sum of two kidneys for control rats
mRNA is strongly expressed) suggests the existence of
different tissue-specific protein isoforms.
Expression of UT mRNA and protein in
kidney medulla
As shown in Figures 3 and 4, a marked fall in UT-A1
mRNA expression was observed after only one week of
renal failure (271%), and the transporter message al-
most completely disappeared later on (297%). The
abundance of UT-A2 and UT-B1 mRNAs also under-
went a considerable fall, although less abrupt (Figs. 3
and 4). These changes were highly significant. mRNA
for G3PDH was normally expressed in the medulla of
Nx rats in comparison to control rats (Fig. 3).
Five weeks after subtotal nephrectomy, the 97 and
117 kD isoforms of UT-A1 were undetectable in medul-
lary extracts, by immunoblotting, and the three bands
of UT-A2 around 50 kD and the 55 kD band of UT-B1
were considerably reduced in uremic rats (Fig. 5).
Expression of UT-B1 mRNA in brain and testis
In the brain, the abundance of UT-B1 mRNA remained
normal one week after Nx but decreased to about one
third of normal (P , 0.01) in the following weeks (Fig. 6).
Interestingly, in the Nx rat with the lowest renal function
(plasma creatinine level around 400 mmol/L), the brain
UT had completely disappeared (one lane before the
last in Fig. 6). In testis, the abundance of UT-B1 relative
to G3PDH was unchanged by CRF (0.80 6 0.03 andFig. 1. Immunoblotting characterization of the anti–UT-B antibody. (A)
Proteins isolated from oocytes injected with H2O or full-length UT-B1 0.85 6 0.03 in Nx and control rats, respectively). The
cRNA or probed with preimmune serum or with rat UT-B antiserum. expression of G3PDH was not influenced by CRF inThe antibody, and not the preimmune serum, recognized a 43 kD
these two organs.protein. A protein amount equivalent to two oocytes was loaded onto
each lane. (B) Proteins from the upper (a) and lower (b) parts of inner
stripe of outer medulla and of inner medulla (15 mg/lane) and from
brain and testis (30 mg/lane) of a normal rat. The antibody recognized DISCUSSION
a dense band of 55 kD in renal medulla. Note an additional faint band
After the cloning of three major urea transportersof 60 kD in upper inner medulla. In testis, weak bands were detected
at 60, 55, and 48 kD, and no band was visible in brain. expressed in the kidney and involved in the urinary con-
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Fig. 2. UT-B immunolocalization in inner
stripe of outer medulla of a normal rat, with
the UT-B antiserum (A) and pre-immune se-
rum (B) (cross sections and oblique sections
on top and bottom, respectively). The central
location of the thin structures recognized by
the antiserum in the vascular bundles and their
relative number suggest that they are descend-
ing vasa recta. In the lower panel, the antibody
also labeled small round figures, which corre-
spond to red blood cells trapped in capillaries.
Bars represent 20 mm.
Fig. 3. Northern blot analysis of rUT-A1, UT-A2, UT-B1, and G3PDH mRNA in the renal medulla of control and 5/6 Nx rats. Each lane,
corresponding to a single rat, was loaded with 15 mg total RNA.
centrating mechanism, several studies have addressed but less rapid decline of UT-A2 and UT-B1, the trans-
porters of descending thin limbs and vasa recta involvedthe regulation of their expression in response to acute
and chronic changes in the level of vasopressin [12, 18– in urea recycling. In addition, UT-B1 mRNA was also
greatly decreased in brain, but not in testis.20]. However, to our knowledge, no study has addressed
yet the possible changes occurring in these transporters
Urea transporters in remnant kidneyduring renal failure, a situation in which urinary concen-
trating ability is markedly reduced. The present study The high osmotic pressure achieved in the renal inner
medullary interstitium in the normal kidney is due to thewas thus designed to investigate the alterations in the
expression of renal urea transporters in rats during CRF accumulation of two major solutes: NaCl and urea. The
accumulation of NaCl is permitted by the active pumpinginduced by subtotal nephrectomy. It reveals a rapid and
dramatic fall in UT-A1, the collecting duct vasopressin- occurring in thick ascending limbs and by countercurrent
multiplication in the loops of Henle. In contrast, theregulated transporter that enables the delivery of con-
centrated urea to the deep inner medulla, and a marked accumulation of urea is not known to involve active
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Fig. 4. Densitometry analysis of UT-A1,
UT-A2, and UT-B1 mRNA abundance in the
renal medulla of control and 5/6 Nx rats. The
abundance of mRNAs for the three transport-
ers is expressed relative to that of G3PDH.
Means 6 SEM of five to six rats per group.
*P , 0.05; **P , 0.01; and ***P , 0.001 vs.
respective control group.
transport and rests on the permanent delivery of concen-
trated urea to the deep inner medullary interstitium by
the vasopressin-dependent UT-A1 and on an efficient urea
recycling from ascending vasa recta to descending thin
limbs and vasa recta by UT-A2 and UT-B1, respectively.
It may be interesting to consider how CRF affects the
overall urinary concentrating capacity, on one hand, and
the capacity to concentrate urea, on the other hand. The
fall in urine osmolality and rise in urine flow rate reflect
a significant fall in the ability of the kidney to conserve
water. Different factors may contribute to this defect,
including an impaired responsiveness to vasopressin of
the cortical collecting duct [21], a fall in medullary vaso-
pressin V2 receptor number [22], and in whole kidney
Fig. 5. Western blot analysis showing UT-A1, UT-A2, and UT-B1 aquaporin abundance [23].
proteins in renal medulla of control and 5/6 Nx rats five weeks after The data reported in Table 1 show that the capacitysurgery. Note the disappearance of UT-A1 and the reduced expression
of UT-A2 and UT-B1 in uremic rats. to concentrate urea in the urine is dramatically decreased
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Fig. 6. Northern blot and densitometry analysis of UT-B1 mRNA abundance in the brain of control and 5/6 Nx rats. The abundance of mRNA
for UT-B1 is expressed relative to that of G3PDH mRNA. Means 6 SEM of four to five rats per group. **P , 0.01 vs. control group. Each lane,
corresponding to a single rat, was loaded with 15 mg total RNA.
in CRF, and to a much greater extent than the capacity sion of G3PDH, an enzyme of the glycolysis pathway,
used here as a reference, was unchanged in the sameto concentrate other solutes. This is attested by the fact
RNA extracts.that the U/P urea concentration ratio fell from 196 in
No clues are presently available regarding the mecha-normal rats to only seven in rats with CRF, a 30-fold
nisms responsible for the reduction in mRNA and pro-decrease, whereas the U/P osmolality ratio declined only
tein expression of water channels and UTs in the diseasedfourfold. This observation suggests that the accumula-
kidney. A possible mechanism could involve urea itself.tion of urea in the medullary interstitium was impaired
Actually, the high urea concentration such as that foundto a much greater extent than that of other solutes. In
in CRF, is capable of inducing the transcription of imme-another model of chronic renal disease (pyelonephritis),
diate early genes in cultured renal epithelial cells [25].a failure to recycle urea and accumulate this solute in
As the transcription factors encoded by these genes canthe papilla was already documented [24].
bind to regulatory elements in the genome, they couldThe selective functional impairment in urinary urea-
affect the rate of transcription of UTs. The consequencesconcentrating capacity that is obvious right from the first
of these defects are more obvious. Urea has been knownweek of CRF (with a 20-fold decline in U/P urea) can
a long time to play a major role in the urinary concentrat-be easily explained by the large and early fall in the
ing mechanism [1, 3]. The functional and molecular re-
collecting duct UT revealed in this study. Because of the sults reported here strongly suggest that the overall de-
almost complete disappearance of UT-A1 message and fect in urinary concentrating ability observed in CRF
protein, the capacity of vasopressin to increase the per- is due to an almost complete loss of the capacity to
meability to urea of the terminal collecting duct is proba- accumulate and recycle urea in the medullary intersti-
bly lost, and urea can no longer be delivered to the tium. The accumulation of the other main medullary
papillary interstitium. Interestingly, the disappearance of solute(s) (depending on countercurrent multiplication of
the other two transporters occurred more slowly because the single effect generated in thick ascending limbs) is
they were reduced by less than 50% one-week post-Nx. probably much less affected, and enables urine to remain
However, in established renal failure, the mRNA of all moderately hypertonic to plasma.
three transporters was reduced to 10% or less of that in
Urea transporter in braincontrol rats, and the protein was also markedly reduced.
These abnormalities did not result from a general dam- The expression of a urea transporter in the brain and
cerebellum has been recently disclosed [10, 11, 13], and inage of the remnant kidney medulla because the expres-
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situ hybridization revealed that it is expressed in astrocytes surrounding interstitium, the considerable reduction of
throughout the central nervous system, in Bergmann glia its expression in CRF (if it also occurs in humans) may
in the cerebellum, in ependymal cells lining the cerebral have some responsibility in the dialysis disequilibrium
ventricles, in Mu¨ller cells in the retina, in a small sub- syndrome (DDS). This syndrome is characterized by
group of neurons of the inferior colliculus and dorsal neurologic disorders of central origin (nausea, seizures)
root ganglia, as well as in cells in the anterior pituitary occurring in some patients during rapid hemodialysis and
gland [9]. The functional significance of urea transport is attributed to brain swelling [28, 29]. Involvement of
in these cells is not yet understood. urea in the pathogenesis of this syndrome is supported
The antibody raised against UT-B1 was able to recog- by a number of observations in rats [30–33]. Moreover,
nize the protein expressed in kidney and red cells, but did in patients, DDS was prevented by the use of dialysate
not recognize the protein present in brain and testis, thus
fluid containing urea at a concentration similar to that
suggesting that the same gene may give rise to different,
of the patient’s blood [34]. The “reverse urea hypothesis”organ-specific isoforms. Therefore, it was not possible
proposes that hemodialysis achieves a more rapid clear-to determine whether the large fall observed in UT-B1
ance of urea from plasma than from brain, creating anmRNA in the brain of rats with renal ablation was accom-
osmotic gradient that results in cerebral edema [32]. Thispanied by a similar fall in the expression of the corre-
is further confirmed by recent observations using iso-sponding protein in the present study. However, it seems
tropic diffusion-weighted magnetic resonance imaging.unlikely that a normal level of protein expression could
Brain water content was found to increase by 8% whenbe maintained with such a marked reduction of the corre-
binephrectomized rats were dialyzed with solutions con-sponding message. Thus, it can reasonably be speculated
that UT-B1 protein expression in brain is strongly re- taining no urea, whereas it remained stable when urea
duced in CRF. was present in the bath [33]. We know now that UT-B1
Because the role of UTs in the normal brain is poorly is normally expressed in mostly astrocytes. The present
understood, the immediate consequences of a reduction study, showing the severe reduction of UT-B1 expression
in UT expression on overall brain function remains un- in the brain during CRF, leads to a proposition that a
clear. The brain expresses a significant arginase activity, selective swelling of astrocytes occurs during fast hemo-
which hydrolyzes arginine into urea and ornithine. Orni- dialysis, thus compressing the neurons that are closely
thine may be further metabolized in the polyamine path- surrounded by these cells and leading to the neurological
way, whereas urea might represent a byproduct that needs symptoms of DDS.
to be excreted from the cells. It is thus tempting to assume
It is difficult, at the present time, to imagine whatthat UT-B1 facilitates the disposal of the urea derived
mechanism or signal might be responsible for the markedfrom arginine hydrolysis, as proposed by Berger, Tsuka-
reduction in the expression of UTs in CRF. The highguchi, and Hediger [9]. However, a recent article describ-
urea concentration in plasma and body fluids might obvi-ing the precise localization of arginase II in brain [26]
ously be involved, but this is certainly not sufficient be-revealed a much wider distribution for this enzyme than
cause the fall in expression exhibits a different intensityfor UT-B1. UT-B1 expression is most prominent in astro-
and time course in brain and kidney and does not occurcytes [9], specialized cells that form a network surrounding
in testis. Tissue-specific factors are thus also likely impli-the neurons and controlling the composition of extracel-
lular fluid. A number of cells in which urea is formed cated.
do not exhibit the UT, including neurons and choroid In conclusion, the findings reported in this article re-
plexus. The colocalization of arginase II and UT-B1 seems veal that the defect in urinary concentrating capacity
to concern mostly astrocytes, suggesting that a rapid urea observed during CRF concerns mainly urea and is largely
transport in these cells might be more important than due to a massive reduction in the expression of all renal
in other brain cells. It is also conceivable that UT-B1 in UTs. In addition, the present study also reveals a dra-
the brain serves a different function, not related to urea matic decline in the UT present in the brain, thus provid-
transport. A human gene, RACH2, coding for a protein ing new clues for the understanding of the DDS.
that is identical to UT-B1, has been cloned indepen-
dently, by virtue of its ability to complement a G1 cell
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